Description: Working together, we can reimagine medicine to improve and extend people’s lives.
pros (137) novartis (80) novartis pharmaceuticals (27) global healthcare companies (25) oncology drug development (22) cloves (17) fava (16) mcap (6) overgrowth (3) pik3ca mutation (1)
PIK3CA-Related Overgrowth Spectrum (PROS) is a broad-ranging spectrum of overgrowth disorders that share a common link—PIK3CA mutations. 1
You are now leaving the Novartis site and moving to an external website independently operated and not managed by Novartis Pharmaceuticals Corporation. Novartis assumes no responsibility for the site. If you do not wish to leave this site, click Cancel. Or click OK to continue.
1/17 ONC-1154329